News

Dividend growth stocks can make for excellent long-term investments. Their ongoing rate increases allow investors to generate more in dividend income than if they were to just invest in a stale

Viking Therapeutics (NASDAQ: VKTX) is an anomaly of sorts. Despite another underwhelming year for biotech stocks, the metabolic disease specialist has, so far, delivered a staggering 208% return on

A few years ago, in the race to launch a COVID-19 vaccine, Pfizer (NYSE: PFE) stock was a hot buy after the company ended up with a highly successful product in Comirnaty. The uncertainty

Nvidia (NASDAQ: NVDA) is playing a crucial role in the development of artificial intelligence (AI) today thanks to its top-performing graphics processing units (GPUs). These chips power some of the

Genetic database builder 23andMe (NASDAQ: ME) stock slid 10% through 12:05 p.m. ET Tuesday. Curiously, though, the news that 23andMe reported today seemed generally of the "good" variety. The

Some investors might think that $3,000 isn't enough cash to get started in the market, especially when some popular stocks already cost hundreds of thousands of dollars per share. But now that most

When you look at the stock market, valuations can seem stretched for a lot of the megacap names -- not all -- but there are still plenty of deals to be had. In today's video, I will look into a few

Pfizer (NYSE: PFE) investors have been through a lot of ups and downs over the past few years. If you've been on the sidelines, now could be a great time to buy the stock.

Shares of Pfizer have been

Even if you're not an investor like Cathie Wood, who specializes in businesses that claim to have a shot at disrupting their industries, investing in aspiring disruptors can be a great tactic to

Eli Lilly and Novo Nordisk are, so far, the kings of the weight-loss gold rush. Thanks to their medicines, Zepbound and Wegovy, billions in new revenue inflows are assured in the near term.

But

Every good thing must come to an end -- and, eventually, the bull market we're experiencing will, too. Long-term investors must prepare for that to happen at some point.

One of the best ways to do

Searching for investments that can outperform the benchmark S&P 500 index often gets wickedly complicated. If you're new to the investing process, you'll be glad to learn that building a portfolio

You're probably familiar with the old adage, "April showers bring May flowers." And you probably know the punchline to the question, "What do May flowers bring?" (The answer: Pilgrims.)

But what

When it comes to dividend investing, some investors like to invest for income, and if you are searching for income, this is the video for you. Today, we will be looking at three dividend stocks that

There are no sure things in the stock market, but the time-tested strategy of buying high-quality stocks at reasonable prices and holding on tight for years gives you the best chance at success. The

Medtronic (NYSE: MDT) is a top healthcare company and a leading maker of medical devices. At a market cap of more than $100 billion, the business has soundly established itself in the industry. It

The pandemic-influenced revenue gusher from which pharmaceutical giant Pfizer (NYSE: PFE) benefitted a few years ago has trickled down to a small stream. As a result, share prices have fallen and

According to data provided by S&P Global Market Intelligence, shares of DraftKings (NASDAQ: DKNG) dropped by as much as 15.7% in trading this week after the Illinois Senate approved a new budget

When it comes to college prestige, Ivy League schools often sit at or near the top of the pecking order. In exchange for a small fortune -- as of the 2022-2023 academic year, annual tuition and fees

Fool.com contributor Parkev Tatevosian reviews Pfizer (NYSE: PFE) stock for passive income investors.

*Stock prices used were the afternoon prices of May 28, 2024. The video was published on May